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ABSTRACT 
In mammalian cells, actin and myosin have emerged as regulators of nuclear structure and 
function, involved in chromatin remodeling and histone modifications, and in different phases 
of gene transcription. Actin and myosin have also been shown to be incorporated into nascent 
ribonucleoprotein complexes. In the cell nucleus, actin undergoes regulated polymerization 
and this may be linked to yet unknown mechanisms of nuclear reprogramming.  
The aims of this thesis were to gain further insights into the functions of actin and myosin in 
transcription by RNA polymerase I and II (RNAP) and how these mechanisms are regulated. 
We investigated, in particular, the interplay between actin and a form of myosin 1c, termed 
nuclear myosin 1 (NM1), which localizes to the cell nucleus. We found that NM1 interacts 
with the chromatin and with actin to facilitate association of the RNAP with the gene 
promoter and the transcription start site. At this specific location, NM1 also promotes a 
chromatin state compatible with transcription activation. NM1 accomplishes this by 
facilitating chromatin remodeling by the WICH complex, with the subunits WSTF and 
SNF2h, and by promoting epigenetic reprogramming. In paper I and in paper IV, we show 
that these mechanisms apply to both RNAP I and RNAP II transcription activation. In paper 
II, we show that NM1 is regulated by GSK3β through a specific phosphorylation in the NM1 
C-terminus that stabilizes the interaction of NM1 with rDNA chromatin. Finally, we show in 
paper III that knocking down the β-actin gene has a negative effect on transcription by 
RNAP I, which leads to a delay in cell cycle progression and defects in cell growth and 
proliferation. 
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1 GENE EXPRESSION IN EUKARYOTIC CELLS 
Gene expression is a multistep process, which is partly regulated at the chromatin level. The 
structure of chromatin is modified by different factors that either reposition nucleosomes with 
respect to each other or covalently modify histones (Voss and Hager, 2014, Valen and 
Sandelin, 2011). These mechanisms result in establishment of permissive chromatin where 
the DNA is more accessible to the RNA polymerases (RNAP). This mechanism therefore 
facilitates the process of transcription when the DNA is transcribed into messenger RNA 
(mRNA) molecules, which are  subsequently translated into functional proteins (Alberts et 
al., 2008). 
In eukaryotic cells, there are three RNA polymerase enzymes which are highly specialized: 
RNA polymerase II (RNAP II) transcribes protein-coding genes into mRNAs and also 
transcribes other non-coding RNAs (ncRNAs) (Goodfellow and Zomerdijk, 2013); RNA 
polymerase I (RNAP I) transcribes ribosomal DNA (rDNA) into ribosomal RNA (rRNA); 
RNA polymerase III (RNAP III) synthesizes transfer RNA (tRNA) and 5S rRNA (White, 
2008). 
The assembly of RNAPs at the gene promoter in order to begin the transcription process 
requires many factors, including general transcription factors (GTFs), activators and 
mediators, which altogether play vital roles in coordination and orchestration of the different 
transcription phases. Nuclear actin and myosin are among some of these factors that have 
recently been identified to have key roles in transcription as well as in other nuclear functions 
and are therefore believed to be key regulators of gene expression at multiple levels. 
Actin is known to be part of chromatin remodeling complexes (CRC), to bind to all three 
eukaryotic nuclear RNAPs and to specifically interact with the RNAP II at the C-Terminal 
Domain (CTD). Actin is also known to associate with ribonucleoprotein complexes (RNPs) 
co-transcriptionally and to accompany the mature RNPs all the way to cytoplasm. In addition, 
soluble actin molecules shuttle between nuclear and cytoplasmic compartments in a regulated 
manner and this shuttling is dependent on transcriptional rates. Importantly, recent studies 
have also demonstrated that actin works as a complex with nuclear myosin 1 (NM1) to 
regulate gene expression (Percipalle, 2013).  
The work presented in this thesis focuses on the importance of actin and NM1 in nuclear 
functions and highlights their roles in the transcription process of both protein-coding and 
rRNA genes. 
In the next chapter, I will introduce the factors and primary mechanisms in the process of 
transcription by RNAP I and RNAP II, highlighting the efficiency of the process in 
eukaryotic cells. 
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2 RNA POLYMERASE I TRANSCRIPTION 
Ribosomal RNA (rRNA) synthesis is the result of the most abundant transcriptional activity 
in eukaryotic cells. It is assumed to comprise around 50%-60% of all transcriptional activity 
in the interphase nucleus throughout the cell cycle with peaks during S-phase (Schlesinger et 
al., 2009, Goodfellow and Zomerdijk, 2013). rRNA genes are arranged as tandem repeats 
separated from each other by long stretches of intergenic sequences (IGSs). The tandem 
repeats are further organized into arrays, termed nucleolar organization regions (NORs), 
around which the nucleolus is assembled at the exit of mitosis. Not all rRNA genes are active; 
it is believed that only 20-30% of all rRNA genes are actively transcribed (Moss and 
Stefanovsky, 2002, McStay and Grummt, 2008). These genes are found at the junction 
between the fibrillar center (FC) and the dense fibrillar component (DFC), two sub 
compartments within nucleoli (Raska, 2003, Bártová et al., 2010). rDNA transcribed by 
RNAP I, a large multiprotein complex with an average molecular size of 590-kDa, 
comprising 14 subunits. Five of these subunits including , Rbp5, 6, 8, 10, and 12 are shared 
between all three RNAPs (Vannini and Cramer, 2012). 
RNAP I transcribes rDNA into a long pre (precursor) rRNA, the 47S pre-RNA, which is then 
gradually processed into 18S, 28S, and 5S rRNAs (Moore and Steitz, 2002, Goodfellow and 
Zomerdijk, 2013), the mature forms which are then incorporated into ribosomal subunits 
(Moore and Steitz, 2002). Because of its importance in global protein levels and therefore 
cellular growth and proliferation, rRNA synthesis is directly influenced by numerous 
signaling pathways and nutrients (White, 2008, Goodfellow and Zomerdijk, 2013, Drygin et 
al., 2010).  
In the next paragraph I will highlight the different phases of RNAP I transcription  
2.1 RNAP I TRANSCRIPTION PROCESS 
The initiation step takes place at the gene promoter and, in particular, at the upstream control 
element (UCE) and the core promoter element (CORE) where RNAP I and other 
transcription factors are recruited to the gene promoter to form the pre-initiation complex 
(PIC) (Grummt, 2003). In humans, RNAP I assembly is mediated by the upstream binding 
factor (UBF) and selectivity factor 1 (SL1). In mice SL1 is termed TIFIB: in either case, it is a 
protein complex which comprises the TATA Box Binding factor (TBP) and the transcription 
factors TAFI110, 63, and 48 (Goodfellow and Zomerdijk, 2013) (Figure 1-A) . 
UBF is a high mobility group (HMG) protein and it is an essential factor for maximal activity 
of RNAP I (Voit and Grummt, 2001, Drygin et al., 2010). UBF binds to UCE and the core 
promoter (CP) to recruit TIF1B/SL1. Next, phosphorylated TIF1A (RNAP I-specific 
transcription initiation factor) binds to the RNAP I subunit RRN3, the RNAP I-associated 
RRN3 subsequently interacts with UBF and TIF1B/SL1 via its PAF53 subunit (Panov et al., 
2006, Drygin et al., 2010, Goodfellow and Zomerdijk, 2013) and as a result, the polymerase 
becomes recruited to the promoter. These steps lead to the formation of the Pre-Initiation 
Complex (PIC) in a manner that is dependent on a local opening of the chromatin 
  3 
(Goodfellow and Zomerdijk, 2013).  Transcription activation requires some components of 
the sirtuin family of proteins. The deacetylase SIRT7 has recently been shown to be crucial 
for RNAP I transcription through the de-acetylation of the RNAP I subunit PAF53, to 
promote RNAP I association with rDNA and activate rDNA transcription (Chen, 2008). 
Together with UBF, SIRT7 interaction with chromatin remodeling complexes (CRC) and its 
association with the rDNA transcription unit are crucial to regulate rRNA synthesis.  
Once the polymerase is assembled, it becomes engaged in the elongation of pre-rRNA. UBF 
is also involved at this stage of transcription. There is evidence that UBF occupies both the 
gene promoter and the coding region of rRNA genes (O'Sullivan et al., 2002, Schneider, 
2012). In addition UBF is also phosphorylated by ERK, and this mechanism is required for 
RNAP I elongation of nascent pre-rRNA (Moss et al., 2006) (Figure 1-B). Finally, UBF 
competes for DNA binding with linker histone H1 to rDNA. This mechanism ensures 
efficient transcription elongation since depletion of  UBF in mouse cells leads to H1 binding 
to rDNA followed by chromatin compaction (Sanij and Hannan, 2009).  
 
 
Figure 1: Schematic diagram of the RNAP I transcription process. (A) The RNAP I is assembled at 
the gene promoter to form the initiation complex. (B) Dissociation of GTFs from gene promoter to 
allow RNAP I to engaged in elongation stage of RNAP I transcription. 
 
The final step of RNAP I transcription process is termination, which takes place at the IGS, 
downstream of the rDNA sequence. The hall marks for transcription termination is a region 
termed Sal box that contains 10 termination sequences T1-T10. Termination is triggered by 
TTF (transcription termination factor) which binds to the T1-T10 sequences and leads to 
RNAP I cleavage. The cleaved RNAP I is rapidly reassembled at the promoter to start a new 
transcription cycle (Gerber et al., 1997, Goodfellow and Zomerdijk, 2013). 
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2.2 REGULATION 
rDNA transcription is also regulated by other micro environmental factors, such as nutrient 
availability and cellular stress, in both negative and positive ways. For example, under sub-
optimal cellular level of nutrients, RNAP I transcription is down-regulated in contrast to 
enhanced transcription observed upon increased amounts of cellular nutrients (Grummt, 
2003, Moss, 2004, Grummt and Voit, 2010). In addition, transcriptional activity responds in a 
different way upon application of specific forms of cellular stresses (Russell and Zomerdijk, 
2005, Boulon et al., 2010). 
In eukaryotic cells, many oncogenes and tumor suppressors have been identified (Drygin et 
al., 2010). These factors work as key regulators of transcription, and generally speaking, they 
both target the RNAP I, impacting different phases transcription. Oncogenes and tumor 
suppressors interfere with each other’s function. For instance, inactivation of a tumor 
suppressor can lead to hyper activation of one or more oncogenes, which eventually leads to 
elevated transcriptional activity. The opposite happens inactivation of specific oncogenic 
factors. So oncogenes and tumor suppressors can affect transcription levels in either positive 
or negative ways (Drygin et al., 2010). 
c-MYC is one of the best characterized oncogenes (Dang, 1999). Under normal conditions, c-
MYC regulates transcription, it is known to be directly affect the amount of UBF that binds to 
rDNA, so that transcription rate is elevated (Hannan et al., 2013) Moreover, c-MYC induces 
transcription through a chromatin-based mechanism: it interacts directly with chromatin and 
facilitates recruitment of histone acetyl transferases (HAT) to contribute to a more open 
chromatin state compatible with transcription (Hannan et al., 2013).  Mutations in the c-MYC 
gene lead to increased activity of the oncogene and enhanced rRNA transcriptional levels. 
This phenomenon has been correlated with many forms of cancer, including leukemic cases 
such as lymphoma (Drygin et al., 2010, Hannan et al., 2013, Campbell and White, 2014). On 
the other hand, tumor suppressors maintain transcription and cell cycle progression in the 
normal cells, and a loss of function mutation eventually leads to enhanced transcription and 
proliferation activity. The retinoblastoma (pRb) is among the best characterized tumor 
suppressors. In the normal cell, pRb targets UBF and interferes with UBF binding to the 
DNA, which leads to down-regulation in RNAP I transcriptional activity (Drygin et al., 
2010).  
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3 RNA POLYMERASE II TRANSCRIPTION 
RNAP II transcribes protein-coding genes also referred to as class II genes into mRNA. In 
eukaryotic cells the newly synthesized mRNA is exported and translated into functional 
proteins within polyribosomes (Alberts et al., 2008).Transcription by RNAP II consists of a 
number of steps, including formation of the pre-initiation complex (PIC), initiation, 
elongation, and termination. Overall, these mechanisms require a cohort of many factors that 
ensure efficient and correct transcription. The RNAP II enzyme comprises 12 subunits, some 
of which are shared by all three classes of RNAPs as mentioned earlier. A peculiarity of the 
largest RNAP II subunit is the highly conserved CTD which comprises tens of heptapeptide 
repeats (Y1S2P3T4S5P6S7) with conserved serine residues in positions 2 (S2) and 5 (S5). 
During transcription, S2 and S5 are reversibly phosphorylated and this reflects the stage of 
the transcription process (Hsin and Manley, 2012). 
3.1 PRE-INITIATION COMPLEX FORMATION (PIC) 
PIC formation is the first step in the RNAP II transcription process. This step in transcription 
is initiated by the assembly of RNAP II with activator, mediator, and transcription factors 
upstream of the CP, which includes the TATA box and transcription start site (TSS). At the 
CORE, TFIID heterodimerizes with TBP and binds to the TATA element located 
approximately 25-30 nucleotides (nt) upstream of the TSS (Figure 2).This protein-DNA 
interaction is stabilized by another GTF, termed TFIIA. Other GTFs including TFIIB and 
TFIIH interact with RNAP II and this further stabilizes the newly assembled RNAP II at the 
CP (Hahn, 2004, Thomas and Chiang, 2006). Despite the importance of GTFs for PIC 
assembly, other factors are vital to the integrity of PIC formation. These include mediator, 
activators, enhancers and gene-specific transcription factors. During PIC formation, the 
polymerase is still in its inactive configuration (Hahn, 2004). 
 
Figure 2: Schematic diagram summarizing the assembly of PIC component to facilitate the assembly 
of RNAP II at the promoter. 
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3.2 INITIATION 
Following the PIC formation, the polymerase undergoes major conformational changes that 
enable the complex to engage transcription initiation phase. Cyclin-dependent kinase 7 
(CDK7), which is known to be a component of TFIIH, phosphorylates the CTD of the largest 
RNAP II subunit on S5 and this leads to DNA unwinding and activation of the polymerase, 
thus initiating transcription. This is followed by the formation of a short single-stranded DNA 
template (11 to 15 bp long) around the TSS and leads to the positioning of the active cleft of 
RNAP II. Transcription is then initiated by the formation of an initial short RNA molecule in 
the range of 10-30 nt long. The hypophosphorylated form of the polymerase remains 
however stalled due to the fact that S5 phosphorylation facilitates recruitment of negative 
elongation factors (NELFs). As shown below, in order to be fully engaged into the elongation 
phase the RNAP II is further phosphorylated on the CTD of its largest subunit (Guo and 
Price, 2013, Grünberg and Hahn, 2013) (Figure 3). 
 
 
Figure 3: During initiation step of RNAP II a phosphorylation event targeting S5 of RNAP II CTD to 
initiate a primary transcript. 
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3.3 ELONGATION AND TERMINATION 
Commitment of RNAP II to the elongation process mainly occurs through phosphorylation of 
S2 within the heptapeptide repeats of the CTD by the cyclin-dependent kinase 9 (CDK9) to 
form a hyperphosphorylated polymerase. Hyperphosphorylation, in turn, facilitates 
recruitment of the positive elongation factor (p-ELF) that engages the polymerase into the 
elongation process, during which the nascent mRNA is synthesized (Peterlin and Price, 
2006). 
As the polymerase approaches the 3’ end of the active gene, the level of S5 phosphorylation 
drops whereas S2 phosphorylation levels are maintained. Therefore S2 phosphorylation is 
considered a hallmark for the termination process. During termination the 3’ end of the 
mRNA is processed: this involves transcript cleavage and addition of the polyadenylation 
signal AAUAAA, which is recognized by the cleavage and polyadenylation specificity factor 
(CPSF) (Richard and Manley, 2009). S2 phosphorylation plays an important role because it 
facilitates recruitment of polyadenylation factors (such as Pcf11) to form the cleavage and 
polyadenylation complex (Richard and Manley, 2009). The newly formed mRNA is nicked 
20 nt downstream, leading to the end of mRNA synthesis. At the end of this process RNAP II 
disassociates from the DNA and the mRNA is completely cleaved (Richard and Manley, 
2009). 
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4 CHROMATIN AND TRANSCRIPTION 
In eukaryotic cells, the DNA is in the form of chromatin. While this compaction is required in 
order to ensure that the DNA is stored in the cell nucleus, it also causes considerable 
hindrance to the transcription process as the DNA itself is not accessible to the polymerase 
machinery. 
The structure unit of chromatin is termed nucleosome. The nucleosome is made of 147 bp of 
DNA wrapped around histone octamers consisting of H3/H4 tetramers, and a H2A/H4 dimer 
(Kornberg, 1974, Negri et al., 2000, Luger et al., 1997). The main consequence of this 
organization of chromatin  is that the DNA is normally buried and must be made accessible to 
transcription factors and RNAP to allow for transcription (Gilbert and Ramsahoye, 2005). 
This is normally achieved by remodeling the chromatin, a dynamic event that requires 
dedicated machineries such as CRC and histone modifying enzymes. These specialized 
factors alter chromatin prior to transcription and allow transcription factors to access and bind 
to DNA and to start the transcription process.  
Histone modifications target histone tails in different ways to perform several functions, 
including, acetylation (Bernstein et al., 2005, Haberland et al., 2009, Mathis et al., 1978, 
Grunstein, 1997), methylation (Bernstein et al., 2005, Schübeler et al., 2000), 
phosphorylation (Rossetto et al., 2012, DesJarlais and Tummino, 2016), ubiquitination 
(Bannister and Kouzarides, 2011) and, sumoylation (Bannister and Kouzarides, 2011). Such 
modifications leads to activation or repression of the transcription process, for example, 
euchromatin modification leads to transcriptional activation by acetylation of specific 
residues using HAT and/or methylation by histone methyltransferase (HMT) (Li et al., 2007). 
On the other hand, heterochromatin modification leads to inactivation or repression of 
transcription by methylation of a specific residue (Li et al., 2007). 
In transcription, histone modifying enzymes are key players at each step from PIC assembly 
to termination, such that by altering the level of histone acetylation and/or methylation at the 
promoter leads to transcriptional activation or repression (Percipalle et al., 2006, Drygin et 
al., 2010, Strohner et al., 2004). One of the interesting aspect that is still under investigation is 
how histone modifying enzymes and chromatin remodeling complexes are recruited and 
maintained on the chromatin during the transcription process.  
As discussed further in the next chapters, actin and myosin play an important role in the 
coordination of the different chromatin modifications that are required during transcriptional 
activity.  
 
 
  9 
4.1 EPIGENETIC REGULATION 
As mentioned earlier, the chromatin state influences gene activity. The chromatin, in turn, is 
epigenetically regulated through covalent histone modifications that are mediated by 
specialized histone modifying enzymes and allow for transcription to be either activated or 
repressed (Li et al., 2007). Modifications, such as acetylation and methylation, target the 
histone tails and determine the transcriptional state of the chromatin. For instance, acetylation 
of histone H3 on lysine 9 (H3K9ac) is enriched at the promoter and TSS of active genes and 
it is thus considered as an epigenetic mark for active transcription. In contrast, other histone 
modifications represent marks for inactive chromatin. An example is methylation of H3 on 
lysine 9 (H3k9m) (Li et al., 2007). Numerous HATs and HMTs are involved in this process, 
such as the HMT Set/Ash1 and the HATs PCAF and p300 (Li et al., 2007). Because these 
histone modifications are required for transcription activation, the HATs PCAF and p300 are 
believed to function as co-activators for RNAPII transcription (Li et al., 2007). 
4.2 CHROMATIN REMODELLING 
As mentioned earlier, chromatin is made up of nucleosomes and it is a key player in 
transcriptional activation. Alterations in nucleosome position, such as nucleosome 
remodeling, sliding and displacement, all lead to changes in DNA accessibility, rendering the 
DNA more or less available for interactions with transcription factors and RNAP. ATP-
dependent chromatin remodelers (CR) play an essential role: they alter chromatin structure by 
repositioning nucleosomes with respect to each other and this leads to DNA loop formation 
and transcriptional activation. In mammalian cells, there are four major chromatin remodeling 
complexes: SWI2/SNF2h, Mi2/CHD, ISWI/ATPase, and Ino80 (Mohrmann and Verrijzer, 
2005, Percipalle and Farrants, 2006). The SWI/SNF family of remodelers comprises an 
ATPase domain and a so-called bromodomain (Percipalle and Farrants, 2006). They have 
been recently shown to be localized at gene promoters and around TSS (Morris et al., 2014), 
suggesting these CR are positive regulators of many genes. These remodelers use their 
bromodomain modules to interact with acetylated lysine residues; once bound to the 
chromatin, ATP hydrolysis leads to disrupt the interaction between DNA and chromatin 
(Zeng and Zhou, 2002, Sanchez and Zhou, 2009). These mechanisms are believed to be 
important both at the promoter and across the active gene. Therefore, SWI/SNF remodelers 
are likely to play an important role in both transcription activation and elongation. In support 
of these hypothesis, SWI/SNF remodelers have been shown to occupy gene promoter and 
coding sequences (Percipalle et al., 2006, Morris et al., 2014) and in yeast cells, there is 
evidence that these remodelers also accompany the RNAP II machinery during the elongation 
phase either in a direct or indirect way (Schwabish and Struhl, 2007).  
The Ino80 family of remodelers also plays a major role in the regulation of transcriptional 
activation and in DNA repair. The structure of Ino80 remodelers comprises two split ATPase 
domains (Conaway and Conaway, 2009). However, the precise mechanisms of how they 
work are not fully understood. In contrast to SWI/SNF and Ino80, the ISWI remodeler is 
known to be a negative regulator of transcription (Venters and Pugh, 2009).  
 10 
The last CR family is CHD; DNA array experiments have shown that a mutant form of 
CHD1 leads to dysregulation of expression in a limited number of genes (Tran et al., 2000, 
Venters and Pugh, 2009). However, despite this evidence suggesting a regulatory role of 
CHD in gene pathways, it is remains unclear how it functions from a mechanistic point of 
view.  
In transcription CRs are known to play both positive and negative roles (Zhou et al., 2002).  
The NORC complex, for example, which consists of TIP5 and the ATPase subunit Sucrose 
Non Fermented 2h (SNF2h) works as negative regulator by silencing transcription through 
the recruitment of HMTs. This eventually leads to repression of transcription (Zhou et al., 
2002). In addition, another chromatin remodeler, termed WICH, belongs to both the 
SWI/SNF and SWI families. This complex comprises of two proteins, the Williams 
Syndrome Transcription Factor (WSTF) and the SNF2h. Within the WICH complex, WSTF 
binds to the chromatin and recruits the remodeler SNF2h and this is important during 
transcription (Bozhenok et al., 2002, Percipalle et al., 2003). Moreover, mass spectrometry 
data demonstrated that WSTF interacts with the Myb-binding protein 1a (Myb-bp 1a) and 
proto-oncogene DEK (Kappes et al., 2001). Additionally, the WICH complex interacts with 
NM1C to form the multiprotein complex B-WICH that plays major roles in RNAP I 
transcription (Percipalle et al., 2006). 
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5 ACTIN AND MYOSIN IN EUKARYOTIC CELLS 
5.1 ACTIN AND ITS REGULATED POLYMERIZATION STATES 
Actin is a 43-kDa protein and is comprised of three isoforms: α, β and γ (Herman, 1993). 
Actin, in particular, the β-actin isoform, is currently known to be the most abundant and 
conserved protein in eukaryotic cells (Dominguez and Holmes, 2011). Actin is present in cell 
cytoplasm in equilibrium between the monomeric (G) and filamentous (F) forms; this 
equilibrium between G and F actin plays major roles in numerous cellular processes, for 
example, cell motility and signal transduction (Clark and Rosenbaum, 1979, Pederson and 
Aebi, 2002). The transition between the G and F form of actin is an ATP-based process 
where actin constantly polymerizes and depolymerizes. This dynamic mechanism is referred 
to ‘treadmilling’ and is known to produce power force for movement (Paavilainen et al., 
2004, Lee and Dominguez, 2010, Percipalle, 2013). In the treadmilling process, G actin joins 
the barbed end or (+) end in an ATP-bound state (Figure 4). At the other end of the filament, 
the pointed end or (-) end, G actin is released in an ADP-bound state. Addition and release of 
actin monomer is highly regulated by actin binding proteins (ABPs), including profilin and 
cofilin. Cofilin binds to the ADP-bound form of actin and mediates severing of the filament 
and release of ADP-bound actin monomers. Cofilin is in turn released from actin monomers 
and through a nucleotide exchange mechanism actin binds to ATP. The ATP-bound form of 
actin is recognized by profilin which in turn facilitates loading of ATP-bound actin 
monomers to the barbed ends of the growing filament. In this way, cofilin and profilin control 
the dynamic of depolymerization and polymerization of actin during treadmilling   
(Paavilainen et al., 2004, Lee and Dominguez, 2010, Percipalle, 2013) (Figure 4). 
 
Figure 4: The mechanism of actin polymerization and depolymerization by treadmilling, adapted 
from (Percipalle, 2013). 
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Cofilin and profilin are not the only proteins regulating actin polymerization and 
depolymerization. The dynamic changes in actin polymerization are also controlled by co-
factors such as the Arp2/3 complex and the N-WASP (neuronal Wiskott–Aldrich Syndrome 
protein), which required for nucleation and branching of actin filaments respectively 
(Vartiainen, 2008). Actin polymerization can also be controlled by formins which facilitates 
the elongation of actin filaments at the barbed end (Zigmond, 2004). Regulating the 
polymerization state of actin is important to ensure interactions with myosin motors that 
require actin filaments to ensure motion. The interaction between actin and myosin is 
dependent on ATP hydrolysis. Only ADP-bound myosin interacts with actin. In the presence 
of inorganic phosphate when the ATP is reconstituted, ATP-bound myosin leaves actin and 
generates short movement along the actin filament on which it resides. This step is called 
‘power stroke’. Upon ATP hydrolysis, when the myosin is in an ADP-bound form, the 
interaction with actin is reconstituted and a new cycle starts again. This general mechanism is 
fundamental for cytoplasmic processes (Pollard and Korn, 1973). 
Emerging evidence suggests that this mechanism is also important in the eukaryotic cell 
nucleus, where it is involved in transcription (Sarshad and Percipalle, 2014). There is 
evidence that actin also undergoes regulated polymerization  (Baarlink et al., 2013, Belin et 
al., 2013). Possibly this may happen across active genes. Indirect evidence supporting this 
possibility is the discovery that the N-WASP  (Wu et al., 2006) and the Arp2/3 (Yoo et al., 
2007) are involved in transcription across the active gene, that profilin binds to active 
transcription sites (Söderberg et al., 2012) and that cofilin targets RNAP II in an actin 
dependent manner and  is required for transcription elongation (Obrdlik and Percipalle, 
2011).  
5.2 ACTIN-BASED MYOSIN MOTORS 
In eukaryotic cells, myosin proteins are clustered into a large family of proteins that includes 
18 different types. Despite of this complexity, myosin has a conserved function, working as 
an actin-dependent motor that generates force to drive movement through establishment of a 
power stroke. Myosin is abundant in the cytoplasmic compartment and interacts with actin to 
generate movement in a number of processes. The main structure of myosin is generally 
conserved in all isoform and comprises a C-terminus or tail domain that differs in length on 
the basis of the type of myosin and the N-terminus or head domain, which includes the actin 
binding site and ATP-binding pocket. This explains the functional specificity of each type of 
myosin. The first non-canonical myosin was discovered 40 years ago and given the name 
Myosin 1 (Pollard and Korn, 1973). 
Myosin processivity, defined as the time spent interacting with the actin filament, and force 
generation that is created by ATP hydrolysis are crucial parameters for the classification of 
different myosin types. Both parameters have implications on the type of movement 
generated by the individual myosin motor. For instance, myosin V is a highly processive 
motor, which makes it suitable for intracellular transport of vesicles. In contrast, myosin I has 
low processivity and therefore it is not suitable for long-range movement, mostly because it 
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does not spend enough time bound to the actin filament (Coluccio, 2008, Sarshad and 
Percipalle, 2014). Cytoplasmic Myosin 1 is involved in many cellular processes and it is 
ubiquitous. It is, for instance, enriched at microvilli of small intestine epithelial cells where it 
crosslinks acting bundles with the cell membrane (Nambiar et al., 2010). Myosin1 is also 
present in hair cells of the inner ear and regulates ion channel (Cyr et al., 2002). Myosin 1 is 
also enriched in neurons where it is needed together with actin for the formation of membrane 
extensions, a process important for cone motility (Wang et al., 2003).  
In conclusion, myosin 1 is able to generate short movement but due to its low processivity, it 
cannot move cargos over long distances; it is therefore believed to function as crosslinker of 
actin filaments and not as cargo transporter (Coluccio, 2008). 
5.3 ACTIN AND MYOSIN IN NUCLEUS 
Despite many independent observations supporting the presence of actin in the cell nucleus of 
amphibians and animals (Clark and Rosenbaum, 1979, Nakayasu and Ueda, 1983), this 
hypothesis has faced much skepticism over the past 40 years. Many scientists claimed that the 
evidence of actin in the cell nucleus was a result of cytoplasmic contamination partly due to 
the sticky nature of actin itself (Pederson and Aebi, 2002, Pederson and Aebi, 2005, Louvet 
and Percipalle, 2009).  Moreover, F-actin is known to be visualized in the cytoplasm using a 
drug called phalloidin (Wehland et al., 1977) which is not able to detect actin in the cell 
nucleus; therefore, many have adhered to the notion that actin is strictly cytoplasmic protein 
that has no role in the cell nucleus (Percipalle and Visa, 2006). 
Since recent decades, the presence of actin in the cell nucleus has become a consolidated 
notion. In the cell nucleus, actin appears to be involved in numerous functions. Nuclear actin 
is part of CRCs; actin is required for transcription by all nuclear eukaryotic RNA 
polymerases and it is co-transcriptionally assembled into nascent ribonucleoprotein 
complexes (RNPs) (Louvet and Percipalle, 2009, Visa and Percipalle, 2010, Percipalle, 
2013). Furthermore, regulated nuclear actin polymerization has now been observed and these 
mechanisms may be implicated in nuclear reprogramming and DNA repair (Miyamoto et al., 
2011, Baarlink et al., 2013, Belin et al., 2015). 
Many actin binding proteins have also been found in the eukaryotic cell nucleus, including 
several myosin types (see below). Among these myosin forms, the best characterized is a 
form of myosin 1c. Initial evidence for its presence in the cell nucleus dates back to the late 
90s when  electron microscopy analysis using a general antibody against myosin 1 
demonstrated that myosin 1c is present in the cell nucleus and even in the nucleolus (Nowak 
et al., 1997). However, the formal discovery of the first myosin type localizing to the cell 
nucleus came from the laboratory of Primal de Lanerolle. This group found that a novel 
myosin 1C isoform entirely localized to the cell nucleus. This isoform, generally termed as 
nuclear myosin 1 C (NM1), is an alternatively spliced form of the canonical myosin 1c 
(Pestic-Dragovich et al., 2000). 
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Since the discovery of NM1, many myosin isoforms were found to localize in eukaryotic cell 
nucleus, including myosin I, II, V, VI, XVI and XVIII. Although some of these isoforms 
appear to be involved in nuclear functions, their precise mode of action is still not known (see 
Table 1) (de Lanerolle and Serebryannyy, 2011, Sarshad and Percipalle, 2014). 
Table 1: Myosin types in cell nucleus and the potential nuclear function. 
 
Today it is known that myosin 1, encoded by the MYO1C gene in human and Myo1c in 
mouse, is alternatively spliced into three isoforms: canonical myosin 1 protein referred to 
isoform C (Pollard and Korn, 1973), NM1 which is isoform B (Pestic-Dragovich et al., 
2000), and the most recently discovered isoform, called isoform A (Ihnatovych et al., 2012).  
NM1 or isoform B shares a similar structure with the C and A isoforms, the only difference 
being that NM1comprises an extra and unique 16 amino acid long stretch at the N-terminus 
of the protein and it is almost entirely localized in the cell nucleus. Similarly, isoform A 
displays the same structure as isoforms B and C but it has an extra N-terminal peptide of 
about 35 amino acids (Ihnatovych et al., 2012). From functional point of view, not much is 
known about isoform A, except that it is a nuclear protein that localizes to splicing speckles 
and appears to have a tissue-specific distribution (Ihnatovych et al., 2012). In contrast, many 
functions have been ascribed to NM1 (isoform B), including chromatin regulation as part of 
the chromatin remodeling complex B-WICH, transcription, RNA processing and genome 
Type Subtype abbreviation Nuclear function Reference 
 
 
Myosin I 
 
C Myo1c ------- (Pollard and Korn, 1973, 
Nowak et al., 1997) 
B NM1C Transcription factor (Pestic-Dragovich et al., 2000) 
A NM1A Not known  (Ihnatovych et al., 2012) 
Myosin II - MII Transcription factor (Li and Sarna, 2009) 
 
Myosin V 
A MVa Transcription factor (Pranchevicius et al., 2008) 
B MVb Gene regulation of RNAPI (Lindsay and McCaffrey, 2009) 
Myosin VI - MVI Regulate newly transcribed 
mRNA 
(Vreugde et al., 2006) 
Myosin XVI - MXVI Cell cycle regulation (Cameron et al., 2007) 
Myosin 
XVIII 
- MXVIII Not known  (Salamon et al., 2003) 
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organization (Percipalle et al., 2006, Percipalle and Farrants, 2006, Visa and Percipalle, 2010, 
Obrdlik et al., 2010, Sarshad et al., 2013, Almuzzaini et al., 2015, Mehta et al., 2010). 
Furthermore, as outlined in the next sections, NM1 acts synergistically with actin in 
numerous nuclear functions as part of an actomyosin complex (Sarshad and Percipalle, 2014). 
5.4 ACTIN AND MYOSIN IN TRANSCRIPTION 
Actin is not only a component of CRCs but it is also required for ATP-dependent remodeling 
activity (Rando et al., 2002). In mammals, nuclear actin is directly associated with BRG-
associated factor (BAF) to form a complex (Zhao et al., 1998). Although the functional 
significance is yet to be understood, in certain CRCs such as Ino80, actin interacts with 
specific actin-related proteins (ARPs) (Kapoor et al., 2013). As component of CRCs, actin 
probably plays a role at the gene level to ensure that the chromatin is in a permissive state 
prior to polymerase assembly and transcription initiation. Actin as CRCs is likely to have a 
global role that affects the general organization of the genome. 
Although the precise role of actin in CRCs is still under investigation, at the transcriptional 
level we are beginning to have mechanistic insights into how actin functions. Actin is found 
to be associated with RNAP I, II, and III to form a complex (Philimonenko et al., 2004, 
Hofmann et al., 2004, Hu et al., 2004). The interaction with the polymerase machineries 
seems to occur in a conserved manner since actin interacts with the polymerase subunits 
Rbp6 and Rbp8 which are shared among all three nuclear RNAP (Hu et al., 2004). This 
observation suggests that actin has a conserved function in complex with the all three RNAPs 
and this might be in the context of their initial assembly at the gene promoter. 
In the case of RNAP II, Hofmann et al (2004) demonstrated that formation of the PIC 
complex requires β-actin. At the early transcriptional stages, actin also plays an important 
role in escape from pausing, promoter clearance and later on, commitment of RNAP II to 
elongation (Percipalle, 2013). Indeed, there is evidence showing that actin interacts with the 
transcriptional co-activator PSF to facilitate recruitment of the p-TEFB complex required to 
phosphorylate the RNAP II CTD, a mechanism necessary for escape from pausing (Qi et al., 
2011). In mammalian cells, our lab showed that actin interacts with the heterogeneous nuclear 
ribonucleoprotein (hnRNPU), and with the phosphorylated form of the RNAP II CTD 
(Kukalev et al., 2005).  
RNA immunoprecipitation (RIP) assays also showed that the HAT PCAF, actin and hnRNPU 
are simultaneously associated with nascent mRNA during transcription (Obrdlik et al., 2008), 
which indicates that they accompany the elongating RNAP II across the active gene. Indeed it 
was found that actin is in a complex with the hyperphosphorylated form of the polymerase 
which further supports its involvement in the control of transcription elongation (Obrdlik et 
al., 2008). Whether the presence of actin in CRCs functionally correlates with the role of 
actin in complex with the polymerase machineries is currently unclear. (Figure 5) 
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Figure 5: Role of actin in RNAP II transcription process, (Percipalle, 2013). 
 
One of the main questions is whether actin functions with NM1 to facilitate the transcription 
process. This question is highly relevant as NM1 has also been shown to associate with the 
transcription machinery by several independent studies (Sarshad and Percipalle, 2014) . In 
situ run-on assays showed that NM1 is associated with nascent transcription foci both in the 
nucleus and in the nucleolus (Fomproix and Percipalle, 2004). The same study provided the 
first evidence that NM1 and actin are in a complex with the largest RNAP I subunit, 
suggesting that actin and NM1 may have a concerted function in transcription of rRNA genes 
(Fomproix and Percipalle, 2004). A follow up study supported this hypothesis. It was shown 
that NM1 binds the phosphorylated form of TIF-IA whereas actin directly interacts with the 
polymerase machinery (Philimonenko et al., 2004). These results were taken as initial 
evidence that actin and NM1 may facilitate assembly of RNAP I at the gene promoter 
(Philimonenko et al., 2004). 
Indeed, using chromatin immunoprecipitation (ChIP) assays, our lab showed that NM1 
associates with the rRNA gene promoter and it is also found across the entire rRNA gene 
(Percipalle et al., 2006, Ye et al., 2008, Obrdlik et al., 2010). Furthermore, in vitro 
transcription assays antibodies against NM1 impaired RNAP I transcription (Percipalle et al., 
2006). Finally, NM1 gene knockdown by siRNA led to drops in rRNA synthesis supporting a 
direct role for NM1 in rRNA gene transcription in living cells (Sarshad et al., 2013). 
NM1 has also been connected to transcription of protein-coding genes by RNAP II. In vitro, 
incubation of a nuclear lysate with an anti-NM1 antibody led to inhibition of RNAP II 
transcription (Pestic-Dragovich et al., 2000, Hofmann et al., 2006). Although the mechanisms 
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are not understood, a follow up in vitro study provided evidence that NM1 is important for 
the formation of the first phosphodiester bond by RNAP II (Hofmann et al., 2006).  
It is now believed that NM1 has a more general role in RNAP II transcription. A recent 
genome-wide analysis performed by ChIP and deep sequencing (see below for a detailed 
explanation) showed that NM1 broadly associates with a large proportion of RNAP II 
promoters and is required for mRNA synthesis (Almuzzaini et al., 2015). 
Whether NM1 cooperates with actin during the transcription process has been a key question 
to address. Initial insights came from a study by Fomproix and Percipalle (2004) where actin 
and NM1 co-precipitated with RNAP I from nuclear extracts. In this study the motor function 
of NM1 was suggested to be involved in RNAP I transcription. Further mechanistic details 
came from work by the Grummt lab (Ye et al., 2008). In this study, transcriptional analysis 
performed on cells constitutively expressing NM1 mutants showed that ablation of the actin- 
and ATP-binding sites on NM1 negatively regulated transcription of rRNA genes, supporting 
not only the requirement for the myosin motor domain but also a synergistic function of NM1 
and actin in transcription. 
In a recent study from our laboratory, the precise mechanisms through which NM1 and actin 
synergize to activate RNAP I transcription were further dissected (Sarshad et al., 2013). Here, 
NM1 was shown to directly bind the chromatin via its C-terminal domain. When bound to the 
chromatin, NM1 interacts with the RNAP I machinery via a direct interaction with the 
polymerase-associated actin. The interaction between actin and NM1 was found to be 
dependent on the NM1 motor function. Initial evidence indicated that when the chromatin-
bound NM1 does not interact with actin, it associates with the chromatin remodeling complex 
WICH and in particular with the ATPase subunit SNF2h. This interaction stabilizes the B-
WICH complex and its chromatin remodeling activity. Therefore, it is postulated that NM1 
connects the RNA polymerase with a permissive chromatin compatible with transcription 
(Sarshad et al., 2013, Sarshad and Percipalle, 2014). Interestingly, binding of NM1 with the 
chromatin is dependent on a phosphorylation event directly mediated by the glycogen 
synthase kinase (GSK) 3β that phosphorylates Ser1020 within the C-terminal domain 
(Sarshad and Percipalle, 2014, Sarshad et al., 2014). These findings support the idea that the 
actin-NM1 complex involved in transcription may be regulated by multiple intracellular 
signaling pathways with GSK3β as downstream effector. 
Recent evidence from our lab indicates that the above mechanisms were conserved at the 
promoters of RNA polymerase II genes where NM1 binds to the chromatin via its C-terminal 
domain and interacts with actin bound to the RNAP II subunits Rpb6 and Rpb8. Again the 
actin-NM1 interaction depends on the motor domain of NM1. Similarly to RNAP I 
transcription, when NM1 does not interact with actin, NM1 ensures correct assembly and 
WICH-dependent remodeling activity, followed by recruitment of HATs and HMTs that 
provide a chromatin state  which is  compatible with transcription (Almuzzaini et al., 2015) 
(Figure 6). 
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Figure 6: Involvement of actin and NM1 in RNAP I and RNAP II transcription at the PIC formation 
and initiation stage. 
 
5.5 NUCLEAR ACTIN DYNAMICS AND IMPACT ON GENOME ORGANIZATION 
As mentioned above, actomyosin-based mechanisms may be important not only at the gene 
level but also at the genomic level. In other words it is possible that actin-based myosin 
motors may be important for the dynamic organization of the genome during transcription 
activation and repression (Chuang et al., 2006, Dundr et al., 2007, Gieni and Hendzel, 2009). 
Despite the fact that nuclear structure in the eukaryotic cell is highly complex, the nucleus is 
a very well organized compartment. The main structure of the cell nucleus comprises many 
organelles that reflect the complexity of this compartment. The basic structure of the nucleus 
includes the nucleoli, speckles, nuclear pore complex (NPC), Cajal body (CB), and 
chromosomes territories (CT). This organization into subdomains and nuclear organelles 
ensures maintenance of a functional nuclear architecture (Cremer et al., 2000, Cremer and 
Cremer, 2001, Gieni and Hendzel, 2009, Visa and Percipalle, 2010, Pederson, 2011). 
One of the most fascinating aspects related to the functional organization of the cell nucleus 
is that in interphase cells, the chromosomes occupy in a specific, non-random manner, areas 
within the nucleus, normally referred to chromosome territories (CT) (Parada and Misteli, 
2002). While this observation suggests that chromosomes are static structures, several studies 
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point towards the dynamic features of chromosomes since gene-rich chromosome regions 
have a tendency to localize in the interior of the cell nucleus, independently of the territory 
they belong to (Parada and Misteli, 2002, Foster and Bridger, 2005, Dundr et al., 2007). 
These apparent paradoxes have been explained by the fact that gene rich chromosomes loops 
are mostly located in the perichromatin region of chromosomes, located at the boundary 
between chromosome territories. Gene rich loops project outward into the nuclear interior 
upon transcription activation (Chubb et al., 2002, Gasser, 2002, Dundr et al., 2007). This 
ensures that loops originating from different chromosomes and therefore containing different 
genes mingle and define neighborhoods of active transcription where genes are 
simultaneously transcribed. Furthermore, organelles such as speckles and CB are known to be 
present in the nuclear interior and therefore the above mechanisms ensure that gene-rich 
chromosomes loops interact with these organelles as well. 
Importantly, it has been suggested that directional movement of chromosomes loops upon 
transcription activation is partly dependent on actin polymerization and on possible 
interactions with myosin. Indeed, in the past few years, several lines of evidence have 
underscored the importance of actin and myosin in genomic organization. First, expression of 
mutated actin forms where polymerization is either negatively or positively affected lead to 
increases in the speed of long-range gene movement (Chuang et al., 2006). Second, transient 
expression of myosin or treatment with butane dione monoxime (BDM), that impairs the 
motor function of myosin, led to reduced gene positioning (Chuang et al., 2006, Gieni and 
Hendzel, 2009). More direct evidence about the involvement of actin in long-range 
chromosome movement came from a study by Dundr et al (2007). Here, stable cell lines that 
contain a tandem array of 16 tetracycline U2 snRNA genes were found to move away from 
their own territory located in the nuclear periphery into the nuclear interior to interact with 
CB. Movement of this gene-rich locus was negatively affected by expression of a mutated 
form of actin that cannot polymerize (Dundr et al., 2007, Carmo-Fonseca, 2007). 
Although we still do not understand the mechanisms, the above studies and recent evidence 
that regulated actin polymerization occurs in the cell nucleus indicate that actin and myosin 
are likely to have an important role in the functional architecture of the cell nucleus (Belin et 
al., 2013). To address some of the open questions and gain mechanistic insights into the 
importance of nuclear actin as a major player in the context of genomic organization, high 
throughput genome wide technologies are likely to be important. 
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6 CHROMATIN IMMUNOPRECIPITATION AND GENOME-
WIDE ANALYSIS 
6.1 INTRODUCTION TO THE TECHNOLOGY 
In 1985, Solomon and Varshavesky applied the first cross-linking method for protein and 
DNA in vivo (Solomon and Varshavsky, 1985). Since that time, protein-DNA interaction, or 
what is currently known as chromatin immunoprecipitation (ChIP), became a key method to 
investigate molecular mechanisms of regulatory proteins that interact and regulate DNA at 
the transcriptional level (Gilchrist et al., 2009).  
The basic principle of the ChIP assay is based on cross-linking proteins with chromatin in 
living cells. Reversible cross-linking is generally performed with formaldehyde. Following 
the cross-linking, chromatin is isolated and digested or sheared into small fragments, which 
range in size between 200 to 500bp, using chemical or physical methods, such as enzymes or 
sonication, respectively. Sheared chromatin is then cleared to get rid of non-specific binding; 
it is then incubated with a specific antibody against the protein of interest which interacts 
with the chromatin. The chromatin-protein complexes are captured by affinity resins and 
released by reversing cross-linking that finally breaks down the interaction between protein 
and chromatin. The DNA is then extracted and the resulting material is analyzed by PCR, real 
time PCR (qPCR), or hybridization to a specific targeted locus in the genome (Gilbert et al., 
2005, Mahony and Pugh, 2015) (Figure 7). 
Although the ChIP method provided important information at the gene level, for many years 
it was not possible to apply it to a more global analysis to study genomic associations of 
proteins of interests. This dilemma was sorted out in the late 1990s after many advanced 
methods were introduced to study gene-protein interactions on a higher scale using 
comparative genomic hybridization (CGH) microarray and then genome-wide analysis, 
which allows scientists to improve upon the resolution of genomic analysis. In addition to 
that, combining ChIP with a genome-wide sequencing method, such as ChIP-on-Chip or 
ChIP combined with next generation sequencing (ChIP-seq) allow protein interactions with 
millions of base pairs of the genomic sequence to be studied. 
In the next chapter, I will focus on how the ChIP method has gained advantage from the 
development of genome-wide analysis and next generation sequencing. 
6.2 CHROMATIN IMMUNOPRECIPITATION AND DEEP SEQUENCING 
During last decade, several high throughput data analysis methods introduced to the scientific 
community have allowed scientists to conduct more global studies, including genomic, 
epigenomic, and proteomic approaches, by applying high throughput methods in order to 
study different biological questions. Next generation sequencing is among the technologies 
developed extensively during the decades since DNA sequencing was invented by Sanger 
and Gilbert’s group during the 1970’s (Sanger et al., 1977, Maxam and Gilbert, 1977). 
Moreover, since the human genome map was completed in 2004 (Lander et al., 2001, 
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Consortium, 2004), the field of next generation sequencing had developed extensively and 
the mapping of chromatin states has become more feasible, leading to the discovery of the 
mysterious role of chromatin in many biological processes in health and disease. 
ChIP-seq is one of the methods that have gained a lot of advantages from the development of 
next generation sequencing. It was introduced at the end of the last decade (Barski et al., 
2007) and since that time, several chemical reagents and computational analysis software 
have been developed extensively to assist the achievement of high-quality sample preparation 
and more precise and informative downstream data analysis. 
ChIP-seq, like the conventional ChIP method (see figure 5), is used to study transcription 
factors and epigenetic modifications, such as histone modifications and DNA methylation. 
However, ChIP-seq provides a more global overview of the role of TF association with the 
entire genome, which makes it a more robust method. This method is becoming very 
common, necessitating the importance of having a clear pipeline to be able to achieve a high-
quality data set and also very user-friendly software to be used for large-volume data 
processing and downstream analysis. 
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Figure 7: Pipeline of a typical ChIP experiment followed by different types of analyses. A) Cells are 
fixed using formaldehyde to cross-link and preserve protein-DNA interaction, following by chromatin 
isolation and chromatin shearing into small fragments normally achieved by sonication. B) Chromatin 
fragments are subjected to immunoprecipitation with an antibody specific to the protein of the interest; 
generally, about 10% of chromatin is kept aside to be used at a later stage as “Input” reference for 
normalization. C) The crosslinking is reversed to break DNA-protein interactions and the DNA is 
isolated for analysis by PCR, q-PCR or deep sequencing to determine which DNA fragments of DNA 
interact with the protein of interest. 
 
Next, I will summarize and highlight the most critical steps and conditions for ChIP-seq and 
the main pipeline of analysis. 
Chromatin preparation. Even though ChIP is a standard method for both the conventional 
ChIP method and ChIP-seq, chromatin preparation is a very critical step. Many factors 
involved in this step including cell type, cross-linking method, cross-linking time, and 
shearing method, should be optimized to achieve high-quality chromatin in the size range of 
200-500 bp. To test the efficiency of this step, several validation steps should be conducted 
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using different conditions to achieve the optimal chromatin fragment size. High-quality 
samples comprising 200-500bp fragments and DNA concentrations of 10ng/µl are 
recommended for library construction and subsequent sequencing (Landt et al., 2012). 
Antibody selection. This is one of the most important factors. It is very important to select a 
high quality antibody with low cross reactivity. This could be investigated either by checking 
previous publications, if they are available, or by following the recommendations of the 
manufacturer if the antibody has already been tested and approved for use in the ChIP assay. 
To minimize the risk of having a false positive or false negative, it is important to validate 
every single batch at different concentrations and to use both positive and negative controls. 
Then, it should be checked using a known primer that gave a positive and negative result 
(Landt et al., 2012, Park, 2009).  
Control. In addition to the previous considerations, using a negative control helps to avoid a 
false positive result, which may occur mainly as a result of antibody stickiness or cross 
reactivity. The most commonly used negative control is the input sample, which has total 
DNA from the host sample, IP IgG, which is subjected to the IgG antibody to detect 
nonspecific binding, or IP MOCK, which has no antibody to exclude nonspecific binding 
with beads (Ma and Wong, 2011). 
Sequencing quality metric assessment. Output material from library construction and PCR 
amplification is sequenced using one of the commercially available sequencers, such as the 
Illumina Solexa, ABI SOLID, and Roche 454 platforms. As short reads tend to generate raw 
data, due to the complexity of the data generated by ChIP-seq, proper selection of a 
commercial platform and the accompanying computational data analysis software is 
important. The most favorable platforms for ChIP-seq are the Illumina and Roche 454 given 
the ability of these platforms to provide a high number of reads with a low error (Ma and 
Wong, 2011). Quality control of sequencing data is a very crucial step before proceeding to 
data processing and analysis. Many tools can be used to check data quality and one of the 
most common is the FASTX tool kit, which allows user to trim bases that do not match the 
quality score. This step will allow the elimination and trimming of undesired reads that result 
during sample preparation and library construction (Kaspi et al., 2012, Bailey et al., 2013). 
Mapping. Short reads that pass the QC step then need to be mapped and aligned against a 
reference genome. The main idea of mapping is to identify where exactly those reads are 
allocated in the target genome of the same species and also to be sure that a bias is not 
present. Many software applications are used for this process, such as BOWTIE, MAC, 
BWA, and SOAP (Kaspi et al., 2012, Ma and Wong, 2011). 
Peak calling. After mapping, the peaks that are generated by the sequencer software need to 
be defined as to where exactly those reads bind to the genome. This could be achieved 
through several processes, such as read shifting, background estimation, and peak enrichment 
at the site. Different peak callers software could be used, such as MAC, SPP and SICER 
(Bailey et al., 2013). 
 24 
Annotation and differential analysis. To study the biological implication of the TF that 
interact with DNA, it is important to identify the genes in which those peaks localize; for this, 
the peaks are annotated according to the nearest gene that is localized either upstream or 
downstream of the gene. To do that, peaks that are generated from a peak caller can be 
compared directly to a genome browser, such as UCSC, using an appropriate folder format, 
such as WIG and BED. The output from this step could be used to study specific biological 
processes using certain software, such as DAVID or GREAT (Bailey et al., 2013). 
ChIP-seq data could be taken further into motif analysis to find out if the TF have affinity for 
binding a specific DNA motif. Available tools for this study include MEME and others. 
Currently, many commercial and free software applications are available to perform genomic 
analysis of ChIPed material. In addition, other packages have been introduced to perform the 
analysis, such as GALAXY (Blankenberg et al., 2010) and ChIPseek (Chen et al., 2014), 
web-based packages that are freely available. 
6.3 ADVANTAGES AND DISADVANTAGES 
Earlier studies of TF relied on ChIP-on-chip which was mainly based on hybridization 
methods. This technique has many drawbacks, mainly because of noise that results from 
hybridization; however, the main advantage of ChIP-seq compared with another high 
throughput technology and, in particular, ChIP-on-chip, is that ChIP-seq does not rely on 
hybridization, minimizing the amount of noise that affects result interpretation. In addition, 
ChIP-seq could be used to detect the binding of TF to any part of the genome with very high 
resolution, since binding is not ambiguous, moreover, it needs less material to start up the 
method compared with ChIP-on-chip (Park, 2009). However, ChIP-seq has many technical 
and logistic limitations and disadvantages that affect the power of this method. As discussed 
earlier, the quality of antibody to the protein of interest has a major effect on the final 
outcome of the result. Another limitation is the high cost of library construction preparation, 
sequencers, the cost, lack of free access to data processing software and the lack of 
accessibility to such software (Park, 2009). 
Yet, ChIP-seq is becoming the dominant method to study transcription at the chromatin level 
and has great potential for technological improvements. Improvements in sequencing 
resolution and the lowering cost for both sequencer and computational software will 
definitely enhance the quality of the final result by applying more replicates of each sample. 
This will lead us to uncover many mysterious mechanisms in the transcriptional regulation 
process. 
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7 AIM OF THE THESIS 
The overall goal of the work presented in this thesis was to find out how actin and NM1 
cooperate to regulate gene transcription. 
Specifically, I was interested in the following aspects: 
1- Find out how actin and NM1 synergize for transcription of rRNA genes 
2- Identify how the actomyosin complex is regulated in rRNA gene transcription 
3- Determine the specific contribution of actin in rRNA gene transcription, cell growth 
and proliferation using a loss-of-function model, and  
4- Evaluate the direct contribution of NM1 in transcription of protein coding genes using 
a genome-wide approach 
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8 RESULTS AND SUMMARY 
8.1 PAPER I 
NUCLEAR MYOSIN 1C FACILITATES THE CHROMATIN MODIFICATIONS 
REQUIRED TO ACTIVATE rRNA GENE TRANSCRIPTION AND CELL 
CYCLE PROGRESSION 
Aim   
Based on evidence that NM1 interacts with RNAP I and NM1 is part of the chromatin 
remodeling complex B-WICH, in paper I we investigated how NM1 coordinated 
transcriptional activity by RNA polymerase I and chromatin modifications leading to efficient 
rRNA synthesis.   
Results 
Firstly, we performed ChIP assay in growing cells, and showed that NM1, actin, SNF2h, and 
WSTF bind to rDNA including the promoter, External Transcribed Spacer (ETS), 18S, and 
28S, but not the IGS. However, in mitotic cells when RNAP I transcription is repressed, we 
observed a considerable reduced in NM1, SNF2h and actin occupancy levels across the gene 
whereas UBF and WSTF levels were not affected.  
We therefore investigated how B-WICH is assembled on rRNA gene. By combining co-
immunoprecipitation assay from nuclear extracts of WSTF-silenced cells, we found that 
WSTF is necessary for assembly of the B-WICH complex. WSTF regulates B-WICH 
assembly through rounds of phosphorylation and dephosphorylation events. In mitotic cells 
we found that WSTF becomes heavily phosphorylated and under these conditions it does not 
interact with either NM1 or SNF2h. Although the mechanisms are not known, we concluded 
that WSTF phosphorylation is reversible because in interphase cells, the three proteins were 
found to co-precipitate.  
Next, we studied how NM1 associates with the WICH complex (with the WSTF and SNF2h 
subunits) to form B-WICH. To do this, we used HEK293T cells which constitutively 
expressing wild type and different mutated forms of NM1 tagged in the N-terminus with a V5 
epitope. The mutated NM1 constructs include the ΔRK605AA NM1 lacking the actin binding 
site, the ΔC NM1 lacking the C-terminal domain, and the ΔIQ NM1 lacking the calmodulin 
site with IQ motifs. Co-immunoprecipitation from total nuclear lysates with anti V5 
antibodies showed that ΔRK605AA NM1, as expected, does not interact with actin but avidly 
interacts with endogenous SNF2h. We therefore suggested that when NM1 cannot interact 
with actin, NM1 tends to interact with SNF2h. In ChIP experiments, we also discovered that 
the ΔC NM1 mutant lacking the C-terminal domain does not interact with the rDNA. 
Analysis by micrococcal nuclease (MNase) followed by qPCR performed on chromatin 
isolated from the cells expressing NM1 mutants showed that  NM1 is essential to stabilize the 
B-WICH complex and the chromatin remodeling activity of SNF2h on the rDNA. 
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Furthermore, assembly of the B-WICH complex is a requirement for recruitment of the HAT 
PCAF and H3K9 acetylation. 
Since in the absence of NM1 or upon expression of mutated NM1 constructs we revealed 
significant reduction in the levels of rRNA synthesis, we concluded that NM1 facilitates 
transcription by mediating establishment of permissive chromatin state that is compatible 
with transcription. Using flow cytometry, measurements on cells lacking NM1, we also 
demonstrated that transcriptional activation at the exit of mitosis by NM1 is important to 
maintain effective cell cycle progression.  
In conclusion, we thus suggest that NM1 interacts with rDNA via the C-terminal domain, and 
that NM1 interacts with RNAP I-associated actin. If NM1 cannot interact with RNAP I- 
associated actin, NM1 interacts with WSTF and SNF2h to form the B-WICH complex. This 
interaction leads to the recruitment of the HAT PCAF and acetylation at the Lys residue in 
position 9. This two-step mechanism based on the motor function of NM1 allows 
transcriptional activation, permissive chromatin and cell cycle progression. 
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8.2 PAPER II 
GLYCOGEN SYNTHASE KINASE (GSK) 3β PHOSPHORYLATES AND 
PROTECTS NUCLEAR MYOSIN 1C FROM PROTEASOME-MEDIATED 
DEGRADATION TO ACTIVATE rDNA TRANSCRIPTION IN EARLY G1 
CELLS 
Aim 
Here, we study how NM1 is regulated during RNAP I transcription activation at the exit of 
mitosis.  
Result 
NM1 is one of those proteins that is potentially targeted by the glycogen synthase kinase 
(GSK)3β (Taelman et al., 2010). Previous work from our lab highlighted the importance of 
GSK3β in RNAP I transcription (Vincent et al., 2008). In this study, we therefore 
investigated whether the function of NM1 during RNAP I transcription activation is directly 
regulated by GSK3β. We started addressing this question by studying the possible association 
of GSK3β with the mammalian genome using ChIP-seq with a custom-made antibody against 
the active form of GSK3β. We found that GSK3β occupies the rRNA gene promoter, it is 
present across the entire rDNA transcription unit and it is mostly excluded for the intergenic 
regions. In cells from an embryonic lethal GSK3β knockout mouse, we found that rRNA 
synthesis is repressed, indicating a direct role for GSK3β in RNA polymerase I transcription. 
To find out how GSK3β functions, we investigated gene occupancies of RNAP I, UBF, actin, 
NM1, SNF2h, WSTF in GSK3β wild-type (GSK3β+/+MEFs) and knockout mouse embryonic 
fibroblasts (GSK3β-/-MEFs). ChIP followed by q-PCR analysis showed that in the absence of 
GSK3β, the levels of actin, NM1, and SNF2h at the promoter and across the rRNA gene were 
decreased considerably but not WSTF. This result suggested that GSK3β is important to 
control the levels of the above components across the rDNA unit and this affects RNAP I 
transcription. Indeed we found that in the absence of GSK3β the levels of epigenetic marks 
for active transcription, such as H3K9 acetylation and the corresponding HAT PCAF 
considerably dropped. Consistent with the transcriptionally repressed state of the cell, the 
morphology of nucleoli in the absence of GSK3β were altered. 
Since we detected direct interactions between GSK3β and NM1 but not with actin or other 
components of the B-WICH complex (SNF2h or WSTF), we next tested whether NM1 is a 
substrate for GSK3β. Using a combination of in vitro phosphorylation assay and mass 
spectrometry, we discovered that GSK3β phosphorylates NM1 on the Ser residue located in 
position 1020, right within the chromatin binding C-terminal domain. We discovered that in 
the absence of GSK3β or upon GSK3β pharmacological inhibition NM1 cannot bind to the 
chromatin and it is degraded. This leads to inhibition of rRNA synthesis and delays cell cycle 
progression. 
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Analysis of the nuclear proteome associated with NM1 by mass spectrometry revealed that 
NM1 interacts with the E3 ligase UBR5.Ubiquitination assays we confirmed that UBR5 
polyubiquitinate NM1 in the absence of GSK3β, and this leads NM1 to be degraded by the 
proteasome at the exit of mitosis. 
In conclusion, we found that GSK3β is selectively associated with rDNA. The absence of 
GSK3β results in a considerable drop in RNAP I transcription level and reduction of the 
H3K9ac level. This regulation is primarily exerted by phosphorylating NM1 on the specific 
serine residue 1020, a requirement to stabilize NM1 binding to rDNA and protecting it from 
proteasome-dependent degradation by the E3 ligase UBR5. 
 
  
 30 
8.3 PAPER III  
IN β-ACTIN KNOCKOUTS EPIGENETIC REPROGRAMMING LEADS TO 
RDNA TRANSCRIPTION INACTIVATION, GROWTH AND PROLIFERATION 
DEFECTS 
Aim 
Herein, we set out to investigate the direct role of actin in RNAP I transcription in a loss-of-
function background. To this end, we used mouse embryonic fibroblasts derived from a 
recently established embryonic lethal β-actin knockout mouse model (Tondeleir et al., 2012). 
Result 
Genome wide analysis by ChIP-Seq performed in β-actin wild-type mouse embryonic 
fibroblasts (β-actin+/+MEFs) showed that β actin is present across the rDNA transcription 
unit, occupying the gene promoter and the coding regions. Interestingly we found specific 
enrichments at the enhancer sequence T0 and within the T1-T10 Sal boxes. Although slightly 
different, similar patterns of enrichment were obtained for NM1, WSTF and SNF2h. 
The distribution of actin across the rDNA transcription unit in wild type cells correlated with 
a decreased level of rRNA synthesis in the β-actin knockout MEF (β-actin-/-MEFs), as 
revealed by qPCR measurements and analysis of nucleoli morphology by electron 
microscopy. Remarkably, expression of wild-type β-actin in the β-actin-/-MEFs rescued the 
rRNA levels. However, full rescue was not obtained when expressing mutated forms of β-
actin with altered polymerization activities. These results indicated a direct function of actin 
in RNAP I transcription.  
We next performed ChIP analysis to study occupancies of RNAP I, UBF, NM1, WSTF and 
SNF2h. The main results obtained by qPCR analysis were that the RNAP I machinery and 
NM1 level of occupancy were significantly reduced in the absence of β-actin. Since actin 
directly binds to the RNAP I and to NM1, we concluded that actin bound to the polymerase 
machinery tethers NM1 to the gene which, in turn, interacts with the chromatin to facilitate 
WICH assembly. Indeed, in the absence of β-actin, MNase assay revealed that the chromatin 
was more compact at the T0 sequence and in the Sal Boxes (T1-T10 sequences). ChIP 
experiments specifically showed that at T0 sequence, NM1 and RNAP I were not recruited, 
similarly to the transcription termination factor TTF1, whose recruitment to the T0 sequence 
is necessary for transcription activation. Consistently with this picture, the levels of 
epigenetic marks for active transcription were considerably reduced and the chromatin was 
found in a repressed state with increased levels of H3K4 monomethylation. 
In our working model, actin bound to the RNAP I machinery is therefore required to recruit 
NM1 to the rDNA. At T0, binding of NM1 is important for B-WICH assembly, nucleosome 
repositioning and epigenetic modifications that locally prepare the chromatin for TTF1 
binding and transcription activation. 
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8.4 PAPER IV 
NUCLEAR MYOSIN 1 CONTRIBUTES TO A CHROMATIN LANDSCAPE 
COMPATIBLE WITH RNA POLYMERASE II TRANSCRIPTIONAL ACTIVATION 
Aim 
In this study, we investigated the genomic distribution of NM1 to determine whether NM1 
interacts with protein-coding genes and whether NM1 is required for RNAP II transcription 
activation. To test this hypothesis, we performed high-throughput analysis and applied 
numerous molecular and biochemical methods. 
Results 
The results from our ChIP-seq analysis performed on chromatin isolated from MEF using an 
antibody against NM1 showed that NM1 is associated with the entire mouse genome, 
including intergenic regions, introns and genes promoters. Promoter binding included the 
TSS, whereas exon regions showed a lesser degree of binding. These findings were validated 
by ChIP-qPCR in selected genes where NM1 was found to be associated with and are 
involved in different biological functions. Using the genome browser (UCSC) we found that 
NM1 distribution at the transcription start sites of protein coding or class II correlated with 
RNAP II, H3K9ac, H2K4m3, and H3K27ac, but not with H3K4m1, which marks active 
enhancers and it is also found enriched across repressive chromatin. 
We next knocked down NM1 expression by RNAi gene silencing and we found that indeed 
transcription of class II genes was down regulated in the absence of NM1. Under these 
conditions using ChIP and qPCR analysis, we found that occupancy levels of active RNAP 
II, β-actin and the β-actin binding polymerase subunits Rbp6 and Rbp8 at transcription start 
sites of selected genes were significantly down-regulated. These results indicated a role for 
NM1 in maintaining the active polymerase at the transcription site together with the 
polymerase-associated actin. 
In view of the above results, we investigated whether NM1 facilitates the association of 
RNAP II at the transcription start site by ensuring the correct chromatin configuration for 
transcription activation. To answer this question, we studied whether SNF2ha and WSTF 
occupancies at the transcription start sites were affected in the absence of NM1. Indeed, 
SNF2h level significantly dropped and this resulted in a more compacted chromatin 
organization, as revealed by micrococcal nuclease and qPCR analysis performed with primers 
amplifying regions within the transcription start site of selected genes. These results indicated 
that in the absence of NM1, the WICH complex is assembled on the chromatin but it is not 
active and local remodeling of nucleosomes does not take place. Furthermore, we found that, 
upon NM1 gene silencing, there is a massive drop in H3K9ac, H3K4m3, and H3K27ac, but 
not H3K4m1. This was accompanied by a reduction in the levels of the HMT Set/Ash1 and 
the HAT PCAF responsible for tri-methylation of H3K4 and acetylation of H3K9, 
respectively. 
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In conclusion, we have shown in this paper the importance of NM1 in the RNAP II 
transcription process. NM1 is associated with the mammalian genome, is needed to facilitate 
the assembly of RNAP II, and is associated with actin by direct protein-protein interaction. 
When NM1 is not interacting with actin, NM1 promotes a local chromatin configuration 
compatible with transcriptional activation by facilitating SNF2h-dependent remodeling and 
the establishment of epigenetic marks for active transcription. 
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9 GENERAL CONCLUSION AND FUTURE    
PRESPECTIVES 
The overall outcome of the research projects in my PhD thesis underscores the importance of 
actin and NM1 in the transcription process. We demonstrated in papers I and IV that actin 
and NM1 interact to activate transcription and allow for permissive chromatin in both RNAP 
I and II transcription processes. In paper II, we showed GSK3β regulates NM1 by 
phosphorylating a specific Ser amino acid residue in the C–terminal domain. This 
posttranslational modification stabilizes NM1 by protecting it from proteasome-mediated 
degradation. GSK3β-dependent NM1 phosphorylation is also important for NM1 binding to 
the rDNA at the onset of RNAP I transcription activation. By regulating NM1 activity, this 
mechanism also controls the actomyosin complex. In paper III, a loss of function study on 
cells lacking the β-actin gene showed that the specific function of the polymerase-associated 
actin is to tether NM1 thus ensuring that the B-WICH complex is stably associated and 
active. This, in turn, facilitates binding of TTF1 with the T0 enhancer sequence and activates 
transcription. An interesting question for further studies is to determine whether this 
mechanism promotes loop formation, enhancing the topology of the rDNA tandem repeats 
prior to transcription initiation. 
Mechanistically we would like to propose that NM1 functions as a molecular switch. Bound 
to the chromatin, NM1 swings between the polymerase-associated actin and the chromatin 
remodeler SNF2h. This mechanism depends on the motor function of NM1 and ultimately 
ensures that (1) the polymerase is firmly associated with the chromatin at the transcription 
start site and (2) by facilitating SNF2h-dependnet remodeling, the chromatin is in a 
permissive state compatible with transcription. 
Although many studies by our group and others have uncovered how actin and myosin are 
likely to cooperate in transcription, there are plenty of questions which are still open for 
further investigations in the future. Today we know that there are at least 6 different species 
of myosin in the nucleus (Sarshad and Percipalle, 2014).  It would be really interesting to find 
out whether these forms of myosin cooperate with actin on different genes or whether their 
synergies with actin depends on yet to be identified signaling pathways that affect nuclear 
function. In this context high throughput analysis at the genome level might be the way to 
address these questions. The results from these experiments have potential to give us insights 
as to whether these mechanisms are general and whether they also have a tissue-specific 
relevance. In the specific case of NM1, this question could be answered by generating an 
animal model where NM1 is not expressed. An attempt has already been made but it was not 
very successful mainly due to the fact that the other isoforms of myosin 1c probably took 
over the function of the ablated NM1 gene (Venit et al., 2013).However, finding a new 
strategy to generate an NM1 knockout model is likely to be rewarding as it might also give us 
insights into the suggested NM1 roles as proliferative factor (Sarshad and Percipalle, 2014) .  
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In addition, analysis of the transcriptome in the absence of actin might be an important step 
forward to evaluate the possibility that nuclear actin is important in nuclear reprogramming 
(Miyamoto et al., 2011, Miyamoto and Gurdon, 2013). 
Working with transcriptional mechanisms is very exciting and promising. The discoveries 
that were made regarding actin and NM1 not only add to the general knowledge of 
transcription, but to the entire fields of nuclear organization and gene expression regulation. 
The main take home message from the work discussed in this thesis is that actin and NM1 are 
general transcription factors for both RNAP I and RNAP II. 
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